Market News Archive
Stay updated with the latest announcements
CITYGENINS: Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the company as 'AAA' rating along with Stable outlook in consideration of its audited financials up to December 31, 2024 also unaudited financials up to March 31, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
REPUBLIC: Buy Confirmation
HR Lines Limited has completed its buying of 11,00,000 shares of Republic Insurance Company Limited at prevailing market price through Dhaka Stock Exchange PLC. as per news disseminated by DSE on 26.06.2025.
TB2Y0826: Record date for entitlement of coupon payment
Record date for entitlement of coupon payment of 2Y BGTB 07/08/2026 Government Securities is 06.08.2025.
POPULARLIF: Resumption after Record Date
Trading of the shares of the company will resume on 30.07.2025.
ASIAINS: Resumption after Record Date
Trading of the shares of the company will resume on 30.07.2025.
UNIONCAP: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 30.07.2025.
GLOBALINS: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 30.07.2025.
NHFIL: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 30.07.2025.
BANKASIA: Sale confirmation of a Sponsor Director
Mr. Rumee A Hossain, a Sponsor Director of the Company, has further informed that he has completed his sale of 2,000,000 shares of the Company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 03.07.2025.
PREMIERBAN: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 30, 2025 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025.
PREMIERBAN: Reschedule of Board Meeting under LR 16(1)
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on July 30, 2025 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.
PREMIERBAN: Reschedule of Board Meeting under LR 19(1)
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on July 30, 2025 at 7:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.
FIRSTFIN: Q2 Financials
(Q2 Un-audited): EPS was Tk. (2.38) for April - June 2025 as against Tk. (0.99) for April - June 2024; EPS was Tk. (3.65) for January - June 2025 as against Tk. (2.92) for January - June 2024; NOCFPS was Tk. (0.51) for January - June 2025 as against Tk. (0.55) for January - June 2024. NAV per share was Tk. (41.51) as on June 30, 2025 and Tk. (34.63) as on June 30, 2024.
CITYGENINS: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.73 for April - June 2025 as against Tk. 0.89 for April - June 2024; EPS was Tk. 1.63 for January - June 2025 as against Tk. 1.74 for January - June 2024; NOCFPS was Tk. 1.98 for January - June 2025 as against Tk. 1.42 for January - June 2024. NAV per share was Tk. 22.47 as on June 30, 2025 and Tk. 21.15 as on December 31, 2024. (cont.)
PRAGATIINS: Q2 Financials
(Q2 Un-audited): EPS was Tk. 1.27 for April - June 2025 as against Tk. 1.24 (restated) for April - June 2024; EPS was Tk. 2.33 for January - June 2025 as against Tk. 2.30 (restated) for January - June 2024; NOCFPS was Tk. (0.60) for January - June 2025 as against Tk. 1.37 (restated) for January - June 2024. NAV per share was Tk. 53.54 as on June 30, 2025 and Tk. 53.82 (restated) as on December 31, 2024.
NRBCBANK: Regarding AGM Venue and Link for 12th AGM of the company
Refer to their earlier news disseminated by DSE on 29.05.2025 regarding dividend declaration, the company has further informed that the AGM will be held through Hybrid system in combination of Digital Platform and Physical Presence at Banquet Hall, Kurmitola Golf Club, Dhaka Cantonment, Dhaka. Link of the AGM: https://nrbcbank.bdvirtualagm.com. Other decisions shall remain unchanged.
EIL: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.14 for April-June 2025 as against Tk. 0.20 for April-June 2024; EPS was Tk. 0.43 for January-June 2025 as against Tk. 0.51 for January-June 2024. NOCFPS was Tk. 0.78 for January-June 2025 as against Tk. 0.14 for January-June 2024. NAV per share (with revaluation) was Tk. 19.68 as on June 30, 2025 and Tk. 19.29 as on December 31, 2024. NAV per share (without revaluation) was Tk. 18.10 as on June 30, 2025 and Tk. 17.70 as on December 31, 2024.
BRACBANK: Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 1.54 for April - June 2025 as against Tk. 1.25 for April - June 2024; Consolidated EPS was Tk. 3.56 for January - June 2025 as against Tk. 2.62 for January - June 2024; Consolidated NOCFPS was Tk. 44.24 for January - June 2025 as against Tk. 30.99 for January - June 2024. Consolidated NAV per share was Tk. 42.60 as on June 30, 2025 and Tk. 39.38 as on December 31, 2024. (cont.1)
EBL: Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 1.23 for April-June 2025 as against Tk. 1.11 (restated) for April-June 2024; Consolidated EPS was Tk. 2.20 for January-June 2025 as against Tk. 2.02 (restated) for January-June 2024. Consolidated NOCFPS was Tk. 13.49 for January-June 2025 as against Tk. 12.79 (restated) for January-June 2024. Consolidated NAV per share was Tk. 27.71 as on June 30, 2025 and Tk. 26.92 (restated) as on December 31, 2024.
POPULARLIF: Q2 Financials
(Q2 Un-audited): As per consolidated life revenue account of the company for April to June, 2025, excess of total expenses including claims over total income (deficit) was BDT 158.90 million as against excess of total expenses including claims over total income (deficit) of BDT 82.63 million in the corresponding previous period of 2024. Whereas as per consolidated life revenue account of the company for January to June, 2025, excess of total expenses including claims over total income (deficit) (cont.)